Cargando…
Genome-wide transcriptome study in skin biopsies reveals an association of E2F4 with cadasil and cognitive impairment
CADASIL is a small vessel disease caused by mutations in NOTCH3 that lead to an odd number of cysteines in the EGF-like repeat domain, causing protein misfolding and aggregation. The main symptoms are migraine, psychiatric disturbances, recurrent strokes and dementia, being executive function charac...
Autores principales: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7994794/ https://www.ncbi.nlm.nih.gov/pubmed/33767277 http://dx.doi.org/10.1038/s41598-021-86349-1 |
_version_ | 1783669829530550272 |
---|---|
author | Muiño, Elena Maisterra, Olga Jiménez-Balado, Joan Cullell, Natalia Carrera, Caty Torres-Aguila, Nuria P. Cárcel-Márquez, Jara Gallego-Fabrega, Cristina Lledós, Miquel González-Sánchez, Jonathan Olmos-Alpiste, Ferran Espejo, Eva March, Álvaro Pujol, Ramón Rodríguez-Campello, Ana Romeral, Gemma Krupinski, Jurek Martí-Fàbregas, Joan Montaner, Joan Roquer, Jaume Fernández-Cadenas, Israel |
author_facet | Muiño, Elena Maisterra, Olga Jiménez-Balado, Joan Cullell, Natalia Carrera, Caty Torres-Aguila, Nuria P. Cárcel-Márquez, Jara Gallego-Fabrega, Cristina Lledós, Miquel González-Sánchez, Jonathan Olmos-Alpiste, Ferran Espejo, Eva March, Álvaro Pujol, Ramón Rodríguez-Campello, Ana Romeral, Gemma Krupinski, Jurek Martí-Fàbregas, Joan Montaner, Joan Roquer, Jaume Fernández-Cadenas, Israel |
author_sort | Muiño, Elena |
collection | PubMed |
description | CADASIL is a small vessel disease caused by mutations in NOTCH3 that lead to an odd number of cysteines in the EGF-like repeat domain, causing protein misfolding and aggregation. The main symptoms are migraine, psychiatric disturbances, recurrent strokes and dementia, being executive function characteristically impaired. The molecular pathways altered by this receptor aggregation need to be studied further. A genome-wide transcriptome study (four cases paired with three healthy siblings) was carried out, in addition to a qRT-PCR for validation purposes (ten new cases and eight new controls). To study the expression profile by cell type of the significant mRNAs found, we performed an in situ hybridization (ISH) (nine cases and eight controls) and a research in the Single-nuclei Brain RNA-seq expression browser (SNBREB). Pathway analysis enrichment was carried out with Gene Ontology and Reactome. Neuropsychological tests were performed in five of the qRT-PCR cases. The two most significant differentially expressed mRNAs (BANP, p-value = 7.23 × 10(–4) and PDCD6IP, p-value = 8.36 × 10(–4)) were selected for the validation study by qRT-PCR. Additionally, we selected two more mRNAs (CAMK2G, p-value = 4.52 × 10(–3) and E2F4, p-value = 4.77 × 10(–3)) due to their association with ischemic neuronal death. E2F4 showed differential expression in the genome-wide transcriptome study and in the qRT-PCR (p = 1.23 × 10(–3)), and it was upregulated in CADASIL cases. Furthermore, higher E2F4 expression was associated with worse executive function (p = 2.04 × 10(–2)) and attention and information processing speed (IPS) (p = 8.73 × 10(–2)). In situ hibridization showed E2F4 expression in endothelial and vascular smooth vessel cells. In silico studies indicated that E2F4 is also expressed in brain endothelial cells. Among the most significant pathways analyzed, there was an enrichment of vascular development, cell adhesion and vesicular machinery terms and autophagy process. E2F4 is more highly expressed in the skin biopsy of CADASIL patients compared to controls, and its expression is present in endothelial cells and VSMCs. Further studies are needed to understand whether E2F4 could be useful as a biomarker, to monitor the disease or be used as a therapeutic target. |
format | Online Article Text |
id | pubmed-7994794 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-79947942021-03-29 Genome-wide transcriptome study in skin biopsies reveals an association of E2F4 with cadasil and cognitive impairment Muiño, Elena Maisterra, Olga Jiménez-Balado, Joan Cullell, Natalia Carrera, Caty Torres-Aguila, Nuria P. Cárcel-Márquez, Jara Gallego-Fabrega, Cristina Lledós, Miquel González-Sánchez, Jonathan Olmos-Alpiste, Ferran Espejo, Eva March, Álvaro Pujol, Ramón Rodríguez-Campello, Ana Romeral, Gemma Krupinski, Jurek Martí-Fàbregas, Joan Montaner, Joan Roquer, Jaume Fernández-Cadenas, Israel Sci Rep Article CADASIL is a small vessel disease caused by mutations in NOTCH3 that lead to an odd number of cysteines in the EGF-like repeat domain, causing protein misfolding and aggregation. The main symptoms are migraine, psychiatric disturbances, recurrent strokes and dementia, being executive function characteristically impaired. The molecular pathways altered by this receptor aggregation need to be studied further. A genome-wide transcriptome study (four cases paired with three healthy siblings) was carried out, in addition to a qRT-PCR for validation purposes (ten new cases and eight new controls). To study the expression profile by cell type of the significant mRNAs found, we performed an in situ hybridization (ISH) (nine cases and eight controls) and a research in the Single-nuclei Brain RNA-seq expression browser (SNBREB). Pathway analysis enrichment was carried out with Gene Ontology and Reactome. Neuropsychological tests were performed in five of the qRT-PCR cases. The two most significant differentially expressed mRNAs (BANP, p-value = 7.23 × 10(–4) and PDCD6IP, p-value = 8.36 × 10(–4)) were selected for the validation study by qRT-PCR. Additionally, we selected two more mRNAs (CAMK2G, p-value = 4.52 × 10(–3) and E2F4, p-value = 4.77 × 10(–3)) due to their association with ischemic neuronal death. E2F4 showed differential expression in the genome-wide transcriptome study and in the qRT-PCR (p = 1.23 × 10(–3)), and it was upregulated in CADASIL cases. Furthermore, higher E2F4 expression was associated with worse executive function (p = 2.04 × 10(–2)) and attention and information processing speed (IPS) (p = 8.73 × 10(–2)). In situ hibridization showed E2F4 expression in endothelial and vascular smooth vessel cells. In silico studies indicated that E2F4 is also expressed in brain endothelial cells. Among the most significant pathways analyzed, there was an enrichment of vascular development, cell adhesion and vesicular machinery terms and autophagy process. E2F4 is more highly expressed in the skin biopsy of CADASIL patients compared to controls, and its expression is present in endothelial cells and VSMCs. Further studies are needed to understand whether E2F4 could be useful as a biomarker, to monitor the disease or be used as a therapeutic target. Nature Publishing Group UK 2021-03-25 /pmc/articles/PMC7994794/ /pubmed/33767277 http://dx.doi.org/10.1038/s41598-021-86349-1 Text en © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Muiño, Elena Maisterra, Olga Jiménez-Balado, Joan Cullell, Natalia Carrera, Caty Torres-Aguila, Nuria P. Cárcel-Márquez, Jara Gallego-Fabrega, Cristina Lledós, Miquel González-Sánchez, Jonathan Olmos-Alpiste, Ferran Espejo, Eva March, Álvaro Pujol, Ramón Rodríguez-Campello, Ana Romeral, Gemma Krupinski, Jurek Martí-Fàbregas, Joan Montaner, Joan Roquer, Jaume Fernández-Cadenas, Israel Genome-wide transcriptome study in skin biopsies reveals an association of E2F4 with cadasil and cognitive impairment |
title | Genome-wide transcriptome study in skin biopsies reveals an association of E2F4 with cadasil and cognitive impairment |
title_full | Genome-wide transcriptome study in skin biopsies reveals an association of E2F4 with cadasil and cognitive impairment |
title_fullStr | Genome-wide transcriptome study in skin biopsies reveals an association of E2F4 with cadasil and cognitive impairment |
title_full_unstemmed | Genome-wide transcriptome study in skin biopsies reveals an association of E2F4 with cadasil and cognitive impairment |
title_short | Genome-wide transcriptome study in skin biopsies reveals an association of E2F4 with cadasil and cognitive impairment |
title_sort | genome-wide transcriptome study in skin biopsies reveals an association of e2f4 with cadasil and cognitive impairment |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7994794/ https://www.ncbi.nlm.nih.gov/pubmed/33767277 http://dx.doi.org/10.1038/s41598-021-86349-1 |
work_keys_str_mv | AT muinoelena genomewidetranscriptomestudyinskinbiopsiesrevealsanassociationofe2f4withcadasilandcognitiveimpairment AT maisterraolga genomewidetranscriptomestudyinskinbiopsiesrevealsanassociationofe2f4withcadasilandcognitiveimpairment AT jimenezbaladojoan genomewidetranscriptomestudyinskinbiopsiesrevealsanassociationofe2f4withcadasilandcognitiveimpairment AT cullellnatalia genomewidetranscriptomestudyinskinbiopsiesrevealsanassociationofe2f4withcadasilandcognitiveimpairment AT carreracaty genomewidetranscriptomestudyinskinbiopsiesrevealsanassociationofe2f4withcadasilandcognitiveimpairment AT torresaguilanuriap genomewidetranscriptomestudyinskinbiopsiesrevealsanassociationofe2f4withcadasilandcognitiveimpairment AT carcelmarquezjara genomewidetranscriptomestudyinskinbiopsiesrevealsanassociationofe2f4withcadasilandcognitiveimpairment AT gallegofabregacristina genomewidetranscriptomestudyinskinbiopsiesrevealsanassociationofe2f4withcadasilandcognitiveimpairment AT lledosmiquel genomewidetranscriptomestudyinskinbiopsiesrevealsanassociationofe2f4withcadasilandcognitiveimpairment AT gonzalezsanchezjonathan genomewidetranscriptomestudyinskinbiopsiesrevealsanassociationofe2f4withcadasilandcognitiveimpairment AT olmosalpisteferran genomewidetranscriptomestudyinskinbiopsiesrevealsanassociationofe2f4withcadasilandcognitiveimpairment AT espejoeva genomewidetranscriptomestudyinskinbiopsiesrevealsanassociationofe2f4withcadasilandcognitiveimpairment AT marchalvaro genomewidetranscriptomestudyinskinbiopsiesrevealsanassociationofe2f4withcadasilandcognitiveimpairment AT pujolramon genomewidetranscriptomestudyinskinbiopsiesrevealsanassociationofe2f4withcadasilandcognitiveimpairment AT rodriguezcampelloana genomewidetranscriptomestudyinskinbiopsiesrevealsanassociationofe2f4withcadasilandcognitiveimpairment AT romeralgemma genomewidetranscriptomestudyinskinbiopsiesrevealsanassociationofe2f4withcadasilandcognitiveimpairment AT krupinskijurek genomewidetranscriptomestudyinskinbiopsiesrevealsanassociationofe2f4withcadasilandcognitiveimpairment AT martifabregasjoan genomewidetranscriptomestudyinskinbiopsiesrevealsanassociationofe2f4withcadasilandcognitiveimpairment AT montanerjoan genomewidetranscriptomestudyinskinbiopsiesrevealsanassociationofe2f4withcadasilandcognitiveimpairment AT roquerjaume genomewidetranscriptomestudyinskinbiopsiesrevealsanassociationofe2f4withcadasilandcognitiveimpairment AT fernandezcadenasisrael genomewidetranscriptomestudyinskinbiopsiesrevealsanassociationofe2f4withcadasilandcognitiveimpairment |